Gitta Boons studied Biochemistry and Biotechnology at the University of Antwerp, where she developed an early interest in cancer research. She conducted her Master’s thesis at the Laboratory for Translational Research and Microfluidics at Paris Descartes University and pursued an FWO-funded PhD in oncogenetics at the University of Antwerp. Her PhD research about (epi)genetic alterations as (liquid) cancer biomarkers sparked her interest in bioinformatics, which resulted in a BanaBa in Bioinformatics at the Howest. Since 2022, she has been working as a Data Scientist at myNEO Therapeutics, where she contributes to the development and refinement of the company’s neoantigen discovery pipeline. Her work focuses on advancing computational approaches for personalized cancer immunotherapies, while also leading and supporting a broad range of internal and collaborative projects.